Consequences of Withholding Erythropoiesis-Stimulating Agents in Hospitalized Patients,
Role: PI,
LLU Dept. of Pharmacy Practice,
(08/2024)
Status: Approved
Assessing hypertension management and establishing targets in adult inpatients undergoing hemodialysis,
Role: PI,
LLU Dept. of Pharmacy Practice,
(05/2024)
Status: Approved
Efficacy and safety of antihypertensive additions in medicine inpatients admitted with acute kidney injury with pre-existing hypertension,
Role: PI,
LLU Dept. of Pharmacy Practice,
(05/2024)
Status: Approved
Evaluating the efficacy and safety of DOACs in cirrhotic patients: Child Turcotte Pugh Class B and Beyond,
Role: PI,
LLU Dept. of Pharmacy Practice,
(09/2023)
Status: Approved
Comparison of Sodium Zirconium Cyclosilicate and Sodium Polystyrene Sulfonate in the Treatment of Acute Hyperkalemia,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(09/2023)
Status: Approved
Comparison of direct oral anticoagulants (DOACs) for the treatment of cerebral venous thrombosis,
Role: PI,
LLU Dept. of Pharmacy Practice,
(10/2022)
Status: Approved
Evaluating ceftriaxone dosing for the treatment of spontaneous bacterial peritonitis (SBP),
Role: PI,
LLU Dept. of Pharmacy Practice,
(10/2022)
Status: Approved
Evaluation of Lokelma versus Kayexalate Monotherapy for Acute Hyperkalemia Treatment,
Role: PI,
LLU Dept. of Pharmacy Practice,
(04/2022)
Status: Approved
Use of the Nominal Group Technique to Explore Skills Lab Faculty and Preceptor Perceptions of EPA Readiness,
Role: PI,
LLU Dept. of Pharmacy Practice,
(08/2021 - 06/2023)
Status: Completed
An International Perspective on Important Components for Successful International Pharmacy Collaborations,
Role: PI,
LLU Dept. of Pharmacy Practice,
(07/2021 - 01/2023)
Status: Completed
Ivabradine Therapy Appropriateness and Its Implications for Heart Failure Patients,
Role: PI,
LLU Dept. of Pharmacy Practice,
(03/2021)
Status: Approved
Comparison of the clinical outcomes of piperacillin-tazobactam versus cefepime in the treatment of hospital- acquired pneumonia with mechanical ventilation and/or septic shock,
Role: PI,
LLU Dept. of Pharmacy Practice,
(09/2020 - 10/2021)
Status: Completed
Clinical comparison of carvedilol immediate release (IR) versus controlled release (CR) in patients with heart failure with reduced ejection fraction (HFrEF),
Role: PI,
LLU Dept. of Pharmacy Practice,
(09/2020 - 08/2022)
Status: Completed
The effect of the COVID-19 pandemic on the prescribing practices of opioid and opioid use,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(09/2020)
Status: Approved
Comparing ceftriaxone dosing in SBP patients,
Role: PI,
LLU Dept. of Pharmacy Practice,
(07/2020 - 02/2021)
Status: Completed
Hydration to prevent acute tubular necrosis with intravenous acyclovir (HYNIVA),
Role: PI,
LLU Dept. of Pharmacy Practice,
(02/2020)
Status: Approved
Comparison of sevelamer hydrochloride and sevelamer carbonate in patient outcomes and cost,
Role: PI,
LLU Dept. of Pharmacy Practice,
(01/2020 - 11/2021)
Status: Completed
Impact of naloxone mandate on naloxone prescribing for reversal of opioid overdose,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(12/2019)
Status: Approved
The effect of the CURES mandate on prescribing practices of class II - IV controlled substances and naloxone,
Role: PI,
LLU Dept. of Pharmacy Practice,
(12/2019 - 07/2023)
Status: Completed
Loading vs. No loading of Apixaban in ESRD patients with VTE,
Role: PI,
LLU Dept. of Pharmacy Practice,
(12/2019 - 01/2023)
Status: Completed
Assessment of enoxaparin thromboprophylaxis dosing and anti-factor Xa levels in low-weight patients,
Role: PI,
LLU School of Pharmacy,
(09/2015)
Status: Completed
A retrospective study determining the appropriate dosing of epoetin alfa for initiation and titration in patients with anemia of chronic kidney disease,
Role: PI,
LLU Dept. of Pharmacy Practice,
(10/2024)
Status: Approved